Perinatal management of fetal congenital heart disease in the era of COVID-19.

Masuda, Hitomi; Inuzuka, Ryo; Toshimitsu, Masatake; Kashima, Kohei; Matsui, Hikoro

Masuda, Hitomi; Inuzuka, Ryo; Toshimitsu, Masatake; Kashima, Kohei; Matsui, Hikoro.

Afiliação

Masuda H; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Inuzuka R; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Toshimitsu M; Department of Obstetrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kashima K; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Matsui H; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Pediatr Int ; 64(1): e14932, 2022 01.

Article em En | MEDLINE | ID: mdl-35119174

Assuntos

COVID-19; Cardiopatias Congênitas; Feminino; Feto; Cardiopatias Congênitas/terapia; Humanos; Gravidez; SARS-CoV-2; Ultrassonografia Pré-Natal

Palavras-chave

COVID-19; congenital heart disease; fetal diagnosis; informed consent; precaution

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Cardiopatias Congênitas Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google